• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps

Colonoscopic surveillance for prevention of colorectal cancer in patients with ulcerative colitis, Crohn's disease and polyps

Status:	History
Publication date:	March 2011
Wave:	21
Process:	SCG
Topic area: Cancer Diagnostic procedures Digestive system

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Judith Richardson
Communications manager:	Shalu Kanal
Guidelines commissioning manager:	Caroline Keir
Guidelines coordinator:	Emma Banks
Patient involvement lead:	Barbara Meredith
Implementation lead:	Stardom Furamera
Lead collaborating centre:	Short Clinical Guidelines Technical Team (SCGTT)
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	09 October 2009
Consultation on draft scope with stakeholders:	28 Oct - 25 Nov 2009
Consultation on draft guideline with stakeholders:	10 December 2010 - 21 January 2011
Pre-publication check:	TBC
Publication date:	March 2011

Top

 

Project history

Date   Update   17 February 2011   Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received.   February 2011   The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.The Guideline Development Group (GDG) oversees the development process.   21 May 2009   The remit was received from the Department of Health and the Welsh Assembly Government in March 2009 as part of the Institute's 21st wave work programme.

Top

 

Key documents

Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps: guideline development and consultation 27 May 2010 Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps: stakeholder lists and how to register 18 May 2010 Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps: scoping workshop, consultation and final scope 28 October 2009 Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps: pre-publication check 15 September 2010 National Collaborating Centre for Cancer 29 December 2009 Short guideline process 29 December 2009 Colonoscopic surveillance for colorectal cancer in high-risk groups: inflammatory bowel disease and polyps: remit 21 May 2009

This page was last updated: 23 November 2011